Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):9–15. doi: 10.1097/QAI.0b013e3181f63906

Table 1.

Clinical information and summary of clones generated from each time point with associated phenotype.

Samples Age (years) CD4 count CD4 % CD4:CD8 ratio Viral Load Biological Phenotype$ Clones V1-V4 env# Full length env*
TM18A 5.0 1 239 20 0.31 699 740 R5 predicted CCR5, n=19 R5, n=10

TM18B 6.6 202 11 0.13 500 000 R5/R5X4 predicted CCR5, n=9
predicted CXCR4, n=13
R5, n=3
R5X4, n=3

TM18C 7.4 7 1 0.01 177 797 R5/R5X4 predicted CCR5, n=6
predicted CXCR4, n=21
R5, n=6
R5X4, n=3
$

Coreceptor usage previously described 6, 7, 21.

#

Coreceptor usage predicted with C-PSSM.

*

Phenotype determined using NP2.CD4 cell lines expressing either CCR5 or CXCR4.